All Things CLL With Nitin Jain
Healthcare Unfiltered
00:00
The Benefits of Vneetoclax
If a patient had a brought name before if they're relapsing on a brought name or a cala brought name yes the next option should be vneetoclax based therapy now. I'm personally excited about a pinterbrutin which as you mentioned early on was just approved for mental cell lymphoma it is not yet approved for cll but at least it's commercially available so yeah i think we are released then we're talking about kinkletriles like car t and there are lots of kinkletRiles but we really have to focus on that, right?
Transcript
Play full episode
